A 35-year-old man with a history of seasonal rhinitis and asthma presents with pruritus, erythematous papules, and vesicles on his hands and forearms 48 hours after contact with nickel-plated jewelry. Patch testing with nickel sulfate 5% shows erythema and induration at 72 hours. Serum IgE levels are normal. Which of the following best describes the immunological mechanism underlying this reaction?

Explanation

## Type IV Hypersensitivity: Nickel Contact Dermatitis ### Clinical Presentation Analysis The patient's presentation—**delayed onset at 48 hours**, **erythematous papules and vesicles** on skin in contact with nickel, and **positive patch test at 72 hours**—is diagnostic of **Type IV hypersensitivity (delayed-type hypersensitivity, DTH)**. The normal serum IgE excludes Type I (immediate) hypersensitivity. ### Immunological Mechanism: Th1/Th17-Mediated Inflammation **Key Point:** Type IV hypersensitivity is a **T cell-mediated, antibody-independent** reaction that requires two phases: sensitization and elicitation. Nickel acts as a hapten, binding to self-proteins and presenting to the immune system as a foreign antigen. ### Pathophysiology: Two-Phase Response #### Phase 1: Sensitization (First Contact) 1. **Nickel penetrates the epidermis** and binds to self-proteins (e.g., HLA molecules, skin proteins) 2. **Langerhans cells (dendritic cells)** in the epidermis internalize the nickel-protein complex 3. **Antigen presentation** via MHC Class II to naive CD4+ T cells in draining lymph nodes 4. **Th1 and Th17 differentiation** occurs under the influence of IL-12 (Th1) and IL-23/IL-6 (Th17) 5. **Memory T cells** are generated and circulate #### Phase 2: Elicitation (Re-exposure) 1. **Nickel-specific Th1 and Th17 cells** recognize the antigen-MHC complex on Langerhans cells and keratinocytes 2. **Th1 cells** release **IFN-γ**, activating macrophages → TNF-α, IL-6, IL-8 production 3. **Th17 cells** release **IL-17**, recruiting neutrophils and amplifying inflammation 4. **Macrophages and dendritic cells** infiltrate the dermis 5. **Cytokine cascade** (TNF-α, IFN-γ, IL-17, chemokines) recruits additional T cells, neutrophils, and eosinophils 6. **Keratinocyte apoptosis** and **edema** → clinical vesicles and erythema **High-Yield:** The **48–72 hour delay** is characteristic of Type IV DTH because it requires T cell activation, proliferation, and migration to the skin site—much slower than IgE-mediated Type I (seconds to minutes). ### Diagnostic Confirmation **Patch testing** is the gold standard for diagnosing contact sensitization: - **Positive at 48–72 hours**: erythema, induration, papules, vesicles - Indicates prior sensitization with circulating nickel-specific Th1/Th17 memory cells - Normal serum IgE rules out Type I hypersensitivity ### Clinical Pearl This patient's history of seasonal rhinitis and asthma (Type I hypersensitivity conditions) does **not** preclude Type IV sensitization to nickel. The two hypersensitivity types are independent; a patient can have both atopic (Type I) and contact dermatitis (Type IV) conditions simultaneously. ```mermaid flowchart TD A[Nickel exposure & skin penetration]:::outcome --> B[Nickel-protein hapten complex formation]:::action B --> C[Langerhans cell antigen uptake & processing]:::action C --> D[MHC Class II presentation to naive CD4+ T cells]:::action D --> E[Th1/Th17 differentiation in lymph nodes]:::action E --> F[Memory T cell generation & circulation]:::outcome G[Re-exposure to nickel]:::outcome --> H[Th1/Th17 recognition of antigen-MHC]:::action H --> I[Th1 IFN-γ release & macrophage activation]:::action I --> J[Th17 IL-17 release & neutrophil recruitment]:::action J --> K[TNF-α, IL-6, IL-8 production & dermal infiltration]:::action K --> L[Keratinocyte apoptosis, edema, vesicles]:::urgent M[Patch test with nickel sulfate]:::action --> N[Positive at 48-72 hours = DTH sensitization]:::outcome ``` ## Mnemonic: **DELAYED** (Type IV Hypersensitivity Features) - **D**elayed onset (24–72 hours) - **E**ffector T cells (Th1, Th17, CD8+) - **L**ymphocytes and macrophages infiltrate - **A**ntibody-independent (no IgE, IgG, IgM required) - **Y**ield positive patch/intradermal test - **E**xample: contact dermatitis, TB skin test, graft rejection - **D**endritic cells present antigen via MHC Class II ## Comparison: Type IV vs. Type I Hypersensitivity | Feature | Type IV (DTH) | Type I (Immediate) | |---------|---------------|--------------------| | **Onset** | 24–72 hours | Seconds–minutes | | **Effector** | CD4+ Th1/Th17, CD8+ CTL, macrophages | IgE, mast cells, basophils | | **Antibody** | None | IgE | | **Mediators** | Cytokines (IFN-γ, IL-17, TNF-α) | Histamine, tryptase, leukotrienes | | **Serum IgE** | Normal | Elevated | | **Skin test** | Delayed induration (48–72 hrs) | Immediate wheal-flare (15–20 min) | | **Nickel allergy** | Contact dermatitis (Type IV) | Anaphylaxis (Type I, rare) | | **Patch test** | Positive at 72 hours | Negative | | **Intradermal test** | Induration at 24–48 hours | Wheal at 15 minutes | **Warning:** Do NOT confuse Type IV with Type I. A patient with nickel contact dermatitis (Type IV) has a **normal serum IgE** and **negative skin prick test**, but a **positive patch test**. Conversely, a patient with penicillin anaphylaxis (Type I) has **elevated specific IgE** and a **positive skin prick test**, but a **negative patch test**.